Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats-Reference-Cited by-同舟云学术

Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats

Published:2003-03-13 Issue:3 Volume:48 Page:154-156
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Ashby Charles R.,Paul Mousumi,Gardner Eliot L.,Heidbreder Christian A.,Hagan Jim J.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference11 articles.

1. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

2. Abstinent Opiate Abusers Exhibit Conditioned Craving, Conditioned Withdrawal and Reductions in both through Extinction

3. A pharmacologic strategy for the treatment of nicotine addiction

4. Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A

5. 1997. Brain reward mechanisms. In: (eds.). Substance abuse: a comprehensive textbook, 3rd ed. Baltimore: Williams & Wilkins. p 51-85.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blockade of the Dopamine D3 Receptor Attenuates Opioids-Induced Addictive Behaviours Associated with Inhibiting the Mesolimbic Dopamine System;Neuroscience Bulletin;2023-04-11

2. Heroin and its metabolites: relevance to heroin use disorder;Translational Psychiatry;2023-04-08

3. Dopamine D₃/D₂ Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders;Journal of Medicinal Chemistry;2023-01-20

4. Knockout of Dopamine D3 Receptor Gene Blocked Methamphetamine-Induced Distinct Changes of Dopaminergic and Glutamatergic Synapse in the Nucleus Accumbens Shell of Mice;Frontiers in Cellular Neuroscience;2022-05-30

5. A Historical Perspective on the Dopamine D3 Receptor;Therapeutic Applications of Dopamine D3 Receptor Function;2022